Clinical Research Division, Fred Hutch
Dr. Mary-Elizabeth Percival is a hematologic oncologist who specializes in the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome, which is a group of diseases that affect blood-cell formation. Her research focuses on the development of early phase clinical trials for patients with AML to test the effectiveness of new drugs and new combinations of drugs. Dr. Percival is also interested in epidemiological research to better understand the factors that affect survival and outcomes for AML patients. She practices at UW Medicine and Seattle Cancer Care Alliance, Fred Hutch’s clinical-care partner.
Assistant Professor, Division of Hematology
University of Washington School of Medicine
Seattle Cancer Care Alliance
M.S., Stanford University, 2016
M.D., Stanford University, 2007
B.A., Biochemical Sciences, Harvard University, 2000
Study Number: 9966
Study Number: RG1005484
Study Number: 20181166
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email email@example.com or call 206.667.2210